IRIS UniCatt

Ferraccioli, Gianfranco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.719
EU - Europa 7.618
AS - Asia 5.821
SA - Sud America 1.237
AF - Africa 189
OC - Oceania 32
Continente sconosciuto - Info sul continente non disponibili 24
AN - Antartide 1
Totale 23.641
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.501
SG - Singapore 2.763
DE - Germania 1.984
CN - Cina 1.593
SE - Svezia 1.102
BR - Brasile 1.031
IT - Italia 921
PL - Polonia 772
FR - Francia 705
UA - Ucraina 682
IE - Irlanda 382
GB - Regno Unito 323
IN - India 258
VN - Vietnam 258
ID - Indonesia 248
FI - Finlandia 225
RU - Federazione Russa 194
TR - Turchia 125
CA - Canada 113
HK - Hong Kong 99
BE - Belgio 89
BD - Bangladesh 88
AR - Argentina 80
JP - Giappone 68
IQ - Iraq 65
MX - Messico 64
ZA - Sudafrica 62
IR - Iran 37
NL - Olanda 37
ES - Italia 29
EC - Ecuador 28
VE - Venezuela 28
CI - Costa d'Avorio 27
PK - Pakistan 27
SA - Arabia Saudita 27
AT - Austria 26
AU - Australia 26
KR - Corea 23
MA - Marocco 23
CL - Cile 20
CH - Svizzera 17
CO - Colombia 17
LT - Lituania 16
CZ - Repubblica Ceca 15
UZ - Uzbekistan 15
RO - Romania 14
IL - Israele 13
JO - Giordania 13
EG - Egitto 12
EU - Europa 12
AZ - Azerbaigian 11
DK - Danimarca 11
UY - Uruguay 11
DZ - Algeria 10
AE - Emirati Arabi Uniti 9
KE - Kenya 9
KG - Kirghizistan 9
NP - Nepal 9
PE - Perù 9
TN - Tunisia 9
A2 - ???statistics.table.value.countryCode.A2??? 8
BG - Bulgaria 8
CR - Costa Rica 8
GR - Grecia 8
JM - Giamaica 8
LK - Sri Lanka 8
PY - Paraguay 8
HN - Honduras 7
NO - Norvegia 7
PT - Portogallo 7
TT - Trinidad e Tobago 7
ET - Etiopia 6
LA - Repubblica Popolare Democratica del Laos 6
LV - Lettonia 6
NG - Nigeria 6
SN - Senegal 6
AL - Albania 5
BO - Bolivia 5
HU - Ungheria 5
LB - Libano 5
NZ - Nuova Zelanda 5
TW - Taiwan 5
AM - Armenia 4
AO - Angola 4
EE - Estonia 4
KH - Cambogia 4
PA - Panama 4
PH - Filippine 4
SI - Slovenia 4
GE - Georgia 3
KW - Kuwait 3
KZ - Kazakistan 3
OM - Oman 3
SC - Seychelles 3
SK - Slovacchia (Repubblica Slovacca) 3
A1 - Anonimo 2
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
GH - Ghana 2
HR - Croazia 2
Totale 23.594
Salva come PNG Salva come JPEG
Città #
Chandler 1.287
Singapore 1.192
Ashburn 753
Warsaw 624
Ann Arbor 390
Jacksonville 389
Dearborn 371
Dublin 364
San Mateo 318
Beijing 292
Wilmington 288
Fairfield 273
Nanjing 250
Woodbridge 238
Jakarta 233
Houston 186
New York 184
Cattolica 178
Seattle 178
Boston 171
Los Angeles 157
Munich 154
Lawrence 140
Kraków 121
Milan 116
Hefei 107
Moscow 106
Hong Kong 98
Dallas 95
Redwood City 92
Bremen 91
São Paulo 89
Ho Chi Minh City 86
Marseille 85
Cambridge 83
Brussels 82
Izmir 82
Nürnberg 81
Rome 81
Frankfurt am Main 77
Nanchang 76
Chicago 73
Princeton 68
Hanoi 65
Buffalo 61
Kunming 61
Lancaster 57
Norwalk 57
Boardman 55
Pune 54
Mountain View 50
Helsinki 47
Guangzhou 46
Hebei 46
Shenyang 43
London 42
Tokyo 41
Tianjin 39
Santa Clara 37
University Park 37
Hangzhou 36
Redmond 35
Falls Church 31
Toronto 29
Johannesburg 28
Baghdad 27
Detroit 27
Jiaxing 27
Shanghai 27
Abidjan 26
Changsha 26
Montreal 26
Phoenix 26
Brooklyn 24
The Dalles 24
Zhengzhou 24
Fremont 23
Denver 22
Jinan 22
Rio de Janeiro 22
San Francisco 22
Kent 21
Leawood 21
Nuremberg 21
Orem 21
Seoul 21
Stockholm 21
Turku 21
Andover 20
Augusta 20
Brasília 20
Atlanta 19
Belo Horizonte 19
Chennai 19
Dhaka 19
Paris 18
Washington 18
Naples 17
Porto Alegre 16
Busto Arsizio 15
Totale 12.158
Salva come PNG Salva come JPEG
Nome #
Porphyromonas gingivalis and the pathogenesis of rheumatoid arthritis: analysis of various compartments including the synovial tissue 421
Modeling the ternary complex TCR-Vbeta/CollagenII(261-273)/HLA-DR4 associated with rheumatoid arthritis. 392
The prognostic significance of the Birmingham Vasculitis Activity Score (BVAS) with systemic vasculitis patients transferred to the intensive care unit (ICU) 346
MicroRNA-34a dependent regulation of AXL controls the activation of dendritic cells in inflammatory arthritis 327
Differential synovial tissue biomarkers among psoriatic arthritis and rheumatoid factor/anti-citrulline antibody-negative rheumatoid arthritis 323
Overweight/obesity affects histological features and inflammatory gene signature of synovial membrane of Rheumatoid Arthritis 293
B CELL DEPLETION IN DIFFUSE PROGRESSIVE SYSTEMIC SCLEROSIS: SAFETY, SKIN SCORE MODIFICATION AND IL-6 MODULATION IN AN UP TO THIRTY-SIX MONTHS FOLLOW-UP OPEN-LABEL TRIAL 286
B cell subsets in the joint compartments of seropositive and seronegative RA and non-RA arthritides express memory markers and ZAP-70 and characterize the aggregate pattern irrespectively of the autoantibody status. 244
MicroRNA-155-at the Critical Interface of Innate and Adaptive Immunity in Arthritis. 243
Impatto dell’inquinamento ambientale da benzene e PM10 sulla progressione clinica della sclerosi sistemica: un’analisi di correlazione. 231
Synovial fluid-derived T helper 17 cells correlate with inflammatory activity in arthritis, irrespectively of diagnosis. 207
Proteomic study of salivary peptides and proteins in patients with Sjögren's syndrome before and after pilocarpine treatment 202
MR imaging of atlantoaxial joint in early rheumatoid arthritis. 200
Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis 193
Collagen-specific T cell repertoire in blood and synovial fluid varies with disease activity in Early Rheumatoid Arthritis. 188
Septic sacroiliitis: an uncommon septic arthritis 187
Allocare risorse nel settore di farmaci biologici: il caso di Etanercept per il trattamento dell’artrite reumatoide 187
beta-thymosins and interstitial lung disease: study of a scleroderma cohort with a one-year follow-up 183
Atlantoepistrophic magnetic resonance imaging involvement in early rheumatoid arthritis: an aggressive tight control therapy not fully arresting the disease 182
Proteomic approaches to Sjögren's syndrome: a clue to interpret the pathophysiology and organ involvement of the disease. 179
B-cell subsets in the joint compartments of seropositive and seronegative rheumatoid arthritis (RA) and No-RA arthritides express memory markers and ZAP70 and characterize the aggregate pattern irrespectively of the autoantibody status 179
Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: Potential utility of immunosuppressive therapy in cardiac damage progression 179
Porphyromonas gingivalis and the pathogenesis of rheumatoid arthritis: analysis of various compartments including the synovial tissue. 178
MicroRNA-155 influences B-cell function through PU.1 in rheumatoid arthritis 171
A vascular endothelial growth factor deficiency characterises scleroderma lung disease 171
Long-term efficacy of B cell depletion therapy on lung and skin involvement in diffuse systemic sclerosis 168
Systematic review of the literature and a case report informing biopsy-proven giant cell arteritis (GCA) with normal C-reactive protein 167
Chemerin and PEDF are metaflammation-related biomarkers of disease activity and obesity in rheumatoid arthritis 167
Modeling the Ternary Complex TCR-V beta/CollagenII(261-273)/HLA-DR4 Associated with Rheumatoid Arthritis 163
Preserved cardiorespiratory function and NT-proBNP levels before and during exercise in patients with recent onset of rheumatoid arthritis: the clinical challenge of stratifying the patient cardiovascular risks 163
The role of High-mobility group box protein 1 in collagen antibody-induced arthritis is dependent on Vascular endothelial growth factor. 158
Very early rheumatoid arthritis is the major predictor of major outcome: clinical ACR remission and radiographic non-progression. 157
Proton pump inhibitors in rheumatic diseases: clinical practice, drug interactions, bone fractures and risk of infections 156
An autosomal recessive DNASE1L3-related autoimmune disease with unusual clinical presentation mimicking systemic lupus erythematosus 155
Allele *2 of the HS1,2A enhancer of the Ig regulatory region associates with rheumatoid arthritis 153
Cilostazol improves the response to ischemia in diabetic mice by a mechanism dependent on PPARγ. 153
ZAP-70+ B Cell Subset Influences Response to B Cell Depletion Therapy and Early Repopulation in Rheumatoid Arthritis 152
Haemophilus parasuis (Glaesserella parasuis) as a Potential Driver of Molecular Mimicry and Inflammation in Rheumatoid Arthritis 152
B CELLS IN SYSTEMIC SCLEROSIS: A POSSIBLE TARGET FOR THERAPY 151
Tumour-associated antigens in systemic sclerosis patients with interstitial lung disease: association with lung involvement and cancer risk 150
ENVIRONMENTAL POLLUTION AND SYSTEMIC SCLEROSIS: A PILOT STUDY ON BENZENE AND PARTICULATE EXPOSURE AS RISK FACTORS FOR THE SYSTEMIC MANIFESTATIONS 149
Detection of bone erosions in early rheumatoid arthritis: 3D ultrasonography versus computed tomography 147
Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis 145
Prognostic Role of Ventricular Ectopic Beats in Systemic Sclerosis: A Prospective Cohort Study Shows ECG Indexes Predicting the Worse Outcome 145
Proteome analysis of biological fluids from autoimmune-rheumatological disorders 144
Memory B cell subsets and plasmablasts are lower in early than in long-standing rheumatoid arthritis 144
Body weight, gender and response to TNF-α blockers in axial spondyloarthritis 144
Preliminary classification criteria for the cryoglobulinaemic vasculitis 143
Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease 141
Tapering and discontinuation of TNF-α blockers without disease relapse using ultrasonography as a tool to identify patients with rheumatoid arthritis in clinical and histological remission 137
Synovial features of patients with rheumatoid arthritis and psoriatic arthritis in clinical and ultrasound remission differ under anti-TNF therapy: A clue to interpret different chances of relapse after clinical remission? 137
Synovial tissue derived characteristics are included in a nomogram for the prediction of treatment response in naïve Rheumatoid Arthritis 137
The potential role of Th17 in mediating the transition from acute to chronic autoimmune inflammation: rheumatoid arthritis as a model. 134
Systemic Bone Density at Disease Onset Is Associated With Joint Erosion Progression in Early Naive to Treatment Rheumatoid Arthritis: A Prospective 12-Month Follow-Up Open-Label Study 132
Recommendations for the use of biologic therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology I. Efficacy 131
A paraneoplastic retroperitoneal fibrosis resistant to corticosteroids treated with tamoxifen. 130
Quantitative and semi-quantitative computed tomography analysis of interstitial lung disease associated with systemic sclerosis: A longitudinal evaluation of pulmonary parenchyma and vessels 130
Prognostic Role of Ventricular Ectopic Beats in Systemic Sclerosis: A Prospective Cohort Study Shows ECG Indexes Predicting the Worse Outcome 129
New therapeutic effects of cilostazol in patients with ischemic disorders. 128
PTPN22 1858C>T polymorphism distribution in Europe and association with rheumatoid arthritis: case-control study and meta-analysis 127
Characterization of inflammatory cell infiltrate of scleroderma skin: B cells and skin score progression. 125
Clinical and ultrasonographic remission determines different chances of relapse in early and long standing rheumatoid arthritis. 124
Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis 124
Tumour-associated antigens in systemic sclerosis patients with interstitial lung disease: association with lung involvement and cancer risk 123
Baseline shoulder ultrasonography is not a predictive marker of response to glucocorticoids in patients with polymyalgia rheumatica: A 12-month followup study 123
Selective Inhibitors of T Cell Receptor Recognition of Antigen–MHC Complexes for Rheumatoid Arthritis 123
Obesity as a risk and severity factor in rheumatic diseases (autoimmune chronic inflammatory diseases) 121
Life-threatening arrhythmias in a scleroderma patient: the role of myocardial inflammation in arrhythmic outburst 119
Cilostazol improves the response to ischemia in diabetic mice by a mechanism dependent on PPARγ. 116
Environmental pollution and systemic sclerosis manifestations: a pilot study on benzene and particulate exposure 116
Preserved cardiorespiratory function and NT-proBNP levels before and during exercise in patients with recent onset of rheumatoid arthritis: the clinical challenge of stratifying the patient cardiovascular risks 116
Biomolecular features of inflammation in obese rheumatoid arthritis patients: management considerations 116
Improved Endothelial Function After Endothelin Receptor Blockade in Patients With Systemic Sclerosis 114
Body weight, gender and response to TNF-α blockers in axial spondyloarthritis 114
Artrite reumatoide. Terapia 113
Is Citrullination Required for the Presence of Restricted Clonotypes Reacting With Type II Collagen? Comment on the Article by Chemin et al 111
Thymosin β4 and β10 in Sjögren's syndrome: Saliva proteomics and minor salivary glands expression 111
Biomarkers of Good EULAR Response to the B Cell Depletion Therapy in All Seropositive Rheumatoid Arthritis Patients: Clues for the Pathogenesis 110
Cardiac troponin T and NT-proBNP as diagnostic and prognostic biomarkers of primary cardiac involvement and disease severity in systemic sclerosis: A prospective study 110
Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies 110
Checkpoint inhibitors (CPI) and autoimmune chronic inflammatory diseases (ACIDs): tolerance and loss of tolerance in the occurrence of immuno-rheumatologic manifestations 106
Immune-Guided Therapy of COVID-19 106
The metabolic syndrome: the crossroads between rheumatoid arthritis and cardiovascular risk 103
Paradoxical arthritis occurring during anti-TNF in patients with Inflammatory Bowel Disease: histological and immunological features of a complex synovitis. 103
Development and validation of a new algorithm for attribution of neuropsychiatric events in systemic lupus erythematosus 102
CTLA-4 Ig as an effective treatment in a patient with type I diabetes mellitus and seropositive rheumatoid arthritis 102
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register 101
Long-term retention rate of anakinra in adult onset Still’s disease and predictive factors for treatment response. 101
Gut microbiota analysis in systemic sclerosis according to disease characteristics and nutritional status 101
Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies 101
Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: potential utility of immunosuppressive therapy in cardiac damage progression 100
Body mass index and treatment response to subcutaneous abatacept in patients with psoriatic arthritis: A post hoc analysis of a phase III trial 100
Infectious agents breaking the immunological tolerance: The holy grail in rheumatoid arthritis reconsidered 100
Toll-like receptor 4 mediates endothelial cell activation through NF-κB but is not associated with endothelial dysfunction in patients with rheumatoid arthritis 99
Interleukin-6 and IgA-rheumatoid factor are crucial for baseline erosiveness, and anti-citrullinated peptide antibodies for radiographic progression in early rheumatoid arthritis treated according to a treat-to-target strategy 98
Microvascular heart involvement in systemic autoimmune diseases: The purinergic pathway and therapeutic insights from the biology of the diseases 98
Very early rheumatoid arthritis as a predictor of remission: a multicentre real life prospective study 97
Rheumatoid arthritis and Alzheimer's disease: genetic and epigenetic links in inflammatory regulation 97
Immunosuppressive Therapy (Methotrexate or Cyclophosphamide) in Combination with Corticosteroids in the Treatment of Giant Cell Arteritis: Comparison with Corticosteroids Alone 97
Polymorphisms of the IgH enhancer HS1.2 and risk of systemic lupus erythematosus 96
Totale 15.358
Salva come PNG Salva come JPEG
Categoria #
all - tutte 103.183
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 103.183
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021945 0 0 0 0 0 89 167 38 239 106 255 51
2021/20221.961 219 158 60 102 131 75 69 296 92 141 272 346
2022/20233.649 461 485 283 597 262 434 151 323 416 45 115 77
2023/20241.773 85 543 67 76 50 243 125 94 18 52 270 150
2024/20253.291 73 93 294 118 323 87 75 165 526 293 633 611
2025/20264.769 1.516 288 485 871 1.513 96 0 0 0 0 0 0
Totale 23.924